Trial Outcomes & Findings for Exercise Intervention for LGBT Cancer Survivors (NCT NCT02459769)
NCT ID: NCT02459769
Last Updated: 2023-11-18
Results Overview
Self-reported psychological distress was measured with the Profile of Mood States (POMS) total score among LGBT cancer survivors. The POMS consists of 30 adjectives that subjects rate on a five-point scale with "1" = "Not at all" and "5" = "Extremely" to describe their moods over the past week. The total score can be calculated by adding the raw scores from tension, depression, anger, fatigue and confusion-focused items and then subtracting the vigour-focused items. This will give a value between -24 and 177, with higher scores indicating higher psychological distress.
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
140 participants
Primary outcome timeframe
Assessed at 8 weeks
Results posted on
2023-11-18
Participant Flow
Participant milestones
| Measure |
Dyadic Exercise Intervention for LGBT Survivors
Progressive walking and resistance exercise treatment, prescribed to both cancer survivors and their caregivers (daily walking and 3 times/week resistance prescription for 6 weeks). Cancer survivors and caregivers are also asked to discuss ways they can support one another in a) remaining adherent to exercise, and b) dealing with stress, including LGBT-specific minority stress.
Exercise for Cancer Patients: a standardized, daily, 6 week, home-based, progressive exercise program
|
Individual Exercise Intervention for LGBT Cancer Survivors
Progressive walking and resistance exercise treatment, prescribed solely to cancer survivors (daily walking and 3 times/week resistance prescription for 6 weeks). The caregiver is told not to change his/her exercise behavior in any way.
Exercise for Cancer Patients: a standardized, daily, 6 week, home-based, progressive exercise program
|
Dyadic Exercise Intervention for Caregivers
Progressive walking and resistance exercise treatment, prescribed to both cancer survivors and their caregivers (daily walking and 3 times/week resistance prescription for 6 weeks). Cancer survivors and caregivers are also asked to discuss ways they can support one another in a) remaining adherent to exercise, and b) dealing with stress, including LGBT-specific minority stress.
Exercise for Cancer Patients: a standardized, daily, 6 week, home-based, progressive exercise program
|
Individual Caregivers-No Intervention
A caregiver is defined as any individual whom the cancer survivor nominates as having provided emotional support or tangible assistance without pay during the survivor's cancer experience. No restriction will be placed on caregivers in terms of relationship with the cancer survivor; they can be family members, friends, romantic partners, or community members
|
|---|---|---|---|---|
|
Overall Study
STARTED
|
34
|
32
|
34
|
33
|
|
Overall Study
COMPLETED
|
26
|
28
|
25
|
28
|
|
Overall Study
NOT COMPLETED
|
8
|
4
|
9
|
5
|
Reasons for withdrawal
| Measure |
Dyadic Exercise Intervention for LGBT Survivors
Progressive walking and resistance exercise treatment, prescribed to both cancer survivors and their caregivers (daily walking and 3 times/week resistance prescription for 6 weeks). Cancer survivors and caregivers are also asked to discuss ways they can support one another in a) remaining adherent to exercise, and b) dealing with stress, including LGBT-specific minority stress.
Exercise for Cancer Patients: a standardized, daily, 6 week, home-based, progressive exercise program
|
Individual Exercise Intervention for LGBT Cancer Survivors
Progressive walking and resistance exercise treatment, prescribed solely to cancer survivors (daily walking and 3 times/week resistance prescription for 6 weeks). The caregiver is told not to change his/her exercise behavior in any way.
Exercise for Cancer Patients: a standardized, daily, 6 week, home-based, progressive exercise program
|
Dyadic Exercise Intervention for Caregivers
Progressive walking and resistance exercise treatment, prescribed to both cancer survivors and their caregivers (daily walking and 3 times/week resistance prescription for 6 weeks). Cancer survivors and caregivers are also asked to discuss ways they can support one another in a) remaining adherent to exercise, and b) dealing with stress, including LGBT-specific minority stress.
Exercise for Cancer Patients: a standardized, daily, 6 week, home-based, progressive exercise program
|
Individual Caregivers-No Intervention
A caregiver is defined as any individual whom the cancer survivor nominates as having provided emotional support or tangible assistance without pay during the survivor's cancer experience. No restriction will be placed on caregivers in terms of relationship with the cancer survivor; they can be family members, friends, romantic partners, or community members
|
|---|---|---|---|---|
|
Overall Study
Withdrawal by Subject
|
7
|
4
|
8
|
5
|
|
Overall Study
Lost to Follow-up
|
1
|
0
|
1
|
0
|
Baseline Characteristics
Exercise Intervention for LGBT Cancer Survivors
Baseline characteristics by cohort
| Measure |
Dyadic Exercise Intervention for LGBT Cancer Survivors
n=32 Participants
Progressive walking and resistance exercise treatment, prescribed to both cancer survivors and their caregivers (daily walking and 3 times/week resistance prescription for 6 weeks). Cancer survivors and caregivers are also asked to discuss ways they can support one another in a) remaining adherent to exercise, and b) dealing with stress, including LGBT-specific minority stress.
Exercise for Cancer Patients: a standardized, daily, 6 week, home-based, progressive exercise program
|
Individual Exercise Intervention for LGBT Cancer Survivors
n=31 Participants
Progressive walking and resistance exercise treatment, prescribed solely to cancer survivors (daily walking and 3 times/week resistance prescription for 6 weeks). The caregiver is told not to change his/her exercise behavior in any way.
Exercise for Cancer Patients: a standardized, daily, 6 week, home-based, progressive exercise program
|
Dyadic Exercise Intervention for Caregivers
n=32 Participants
Progressive walking and resistance exercise treatment, prescribed to both cancer survivors and their caregivers (daily walking and 3 times/week resistance prescription for 6 weeks). Cancer survivors and caregivers are also asked to discuss ways they can support one another in a) remaining adherent to exercise, and b) dealing with stress, including LGBT-specific minority stress.
Exercise for Cancer Patients: a standardized, daily, 6 week, home-based, progressive exercise program
|
Individual Caregivers-No Intervention
n=31 Participants
A caregiver is defined as any individual whom the cancer survivor nominates as having provided emotional support or tangible assistance without pay during the survivor's cancer experience. No restriction will be placed on caregivers in terms of relationship with the cancer survivor; they can be family members, friends, romantic partners, or community members
|
Total
n=126 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|
|
Age, Continuous
|
56.3 years
n=93 Participants
|
55.5 years
n=4 Participants
|
56.7 years
n=27 Participants
|
54.5 years
n=483 Participants
|
55.7 years
n=36 Participants
|
|
Sex/Gender, Customized
Male
|
8 Participants
n=93 Participants
|
13 Participants
n=4 Participants
|
9 Participants
n=27 Participants
|
11 Participants
n=483 Participants
|
41 Participants
n=36 Participants
|
|
Sex/Gender, Customized
Female
|
23 Participants
n=93 Participants
|
18 Participants
n=4 Participants
|
23 Participants
n=27 Participants
|
19 Participants
n=483 Participants
|
83 Participants
n=36 Participants
|
|
Sex/Gender, Customized
Transgender Female
|
1 Participants
n=93 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=27 Participants
|
0 Participants
n=483 Participants
|
1 Participants
n=36 Participants
|
|
Sex/Gender, Customized
Transgender Male
|
0 Participants
n=93 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=27 Participants
|
1 Participants
n=483 Participants
|
1 Participants
n=36 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
2 Participants
n=93 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=27 Participants
|
1 Participants
n=483 Participants
|
3 Participants
n=36 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
30 Participants
n=93 Participants
|
31 Participants
n=4 Participants
|
32 Participants
n=27 Participants
|
30 Participants
n=483 Participants
|
123 Participants
n=36 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=93 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=27 Participants
|
0 Participants
n=483 Participants
|
0 Participants
n=36 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=93 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=27 Participants
|
0 Participants
n=483 Participants
|
0 Participants
n=36 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=93 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=27 Participants
|
0 Participants
n=483 Participants
|
0 Participants
n=36 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=93 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=27 Participants
|
0 Participants
n=483 Participants
|
0 Participants
n=36 Participants
|
|
Race (NIH/OMB)
Black or African American
|
2 Participants
n=93 Participants
|
0 Participants
n=4 Participants
|
2 Participants
n=27 Participants
|
0 Participants
n=483 Participants
|
4 Participants
n=36 Participants
|
|
Race (NIH/OMB)
White
|
30 Participants
n=93 Participants
|
31 Participants
n=4 Participants
|
30 Participants
n=27 Participants
|
31 Participants
n=483 Participants
|
122 Participants
n=36 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=93 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=27 Participants
|
0 Participants
n=483 Participants
|
0 Participants
n=36 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=93 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=27 Participants
|
0 Participants
n=483 Participants
|
0 Participants
n=36 Participants
|
|
Region of Enrollment
United States
|
32 Participants
n=93 Participants
|
31 Participants
n=4 Participants
|
32 Participants
n=27 Participants
|
31 Participants
n=483 Participants
|
126 Participants
n=36 Participants
|
|
Sexual Orientation
Lesbian or Gay
|
30 Participants
n=93 Participants
|
31 Participants
n=4 Participants
|
30 Participants
n=27 Participants
|
26 Participants
n=483 Participants
|
117 Participants
n=36 Participants
|
|
Sexual Orientation
Heterosexual or Straight
|
0 Participants
n=93 Participants
|
0 Participants
n=4 Participants
|
1 Participants
n=27 Participants
|
5 Participants
n=483 Participants
|
6 Participants
n=36 Participants
|
|
Sexual Orientation
Bisexual
|
1 Participants
n=93 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=27 Participants
|
0 Participants
n=483 Participants
|
1 Participants
n=36 Participants
|
|
Sexual Orientation
Other
|
1 Participants
n=93 Participants
|
0 Participants
n=4 Participants
|
1 Participants
n=27 Participants
|
0 Participants
n=483 Participants
|
2 Participants
n=36 Participants
|
PRIMARY outcome
Timeframe: Assessed at 8 weeksSelf-reported psychological distress was measured with the Profile of Mood States (POMS) total score among LGBT cancer survivors. The POMS consists of 30 adjectives that subjects rate on a five-point scale with "1" = "Not at all" and "5" = "Extremely" to describe their moods over the past week. The total score can be calculated by adding the raw scores from tension, depression, anger, fatigue and confusion-focused items and then subtracting the vigour-focused items. This will give a value between -24 and 177, with higher scores indicating higher psychological distress.
Outcome measures
| Measure |
Dyadic Exercise Intervention for LGBT Cancer Survivors
n=32 Participants
Progressive walking and resistance exercise treatment, prescribed to both cancer survivors and their caregivers (daily walking and 3 times/week resistance prescription for 6 weeks). Cancer survivor and caregiver are also asked to discuss ways they can support one another in a) remaining adherent to exercise, and b) dealing with stress, including LGBT-specific minority stress.
Exercise for Cancer Patients: a standardized, daily, 6 week, home-based, progressive exercise program
|
Individual Exercise Intervention for LGBT Cancer Survivors
n=31 Participants
Progressive walking and resistance exercise treatment, prescribed solely to cancer survivors (daily walking and 3 times/week resistance prescription for 6 weeks). The caregiver is told not to change his/her exercise behavior in any way.
Exercise for Cancer Patients: a standardized, daily, 6 week, home-based, progressive exercise program
|
|---|---|---|
|
Self-Reported Psychological Distress
|
8.89 score on a scale
Standard Deviation 22.04
|
6.96 score on a scale
Standard Deviation 17.78
|
SECONDARY outcome
Timeframe: Assessed at 8 weeksPopulation: Note that only 30 LGBT survivors from the Dyadic Exercise Intervention and only 27 from the Individual Exercise intervention had analyzable blood, which is why the total number of participants differs from other outcome measures.
The secondary aim is to determine the preliminary effect of EXCAP-PA versus survivor-only EXCAP©® on biological endpoints associated with distress: serum cortisol among LGBT cancer survivors.
Outcome measures
| Measure |
Dyadic Exercise Intervention for LGBT Cancer Survivors
n=30 Participants
Progressive walking and resistance exercise treatment, prescribed to both cancer survivors and their caregivers (daily walking and 3 times/week resistance prescription for 6 weeks). Cancer survivor and caregiver are also asked to discuss ways they can support one another in a) remaining adherent to exercise, and b) dealing with stress, including LGBT-specific minority stress.
Exercise for Cancer Patients: a standardized, daily, 6 week, home-based, progressive exercise program
|
Individual Exercise Intervention for LGBT Cancer Survivors
n=27 Participants
Progressive walking and resistance exercise treatment, prescribed solely to cancer survivors (daily walking and 3 times/week resistance prescription for 6 weeks). The caregiver is told not to change his/her exercise behavior in any way.
Exercise for Cancer Patients: a standardized, daily, 6 week, home-based, progressive exercise program
|
|---|---|---|
|
Biological Endpoints: Cortisol
|
42.97 ng/ml
Standard Deviation 25.83
|
59.20 ng/ml
Standard Deviation 49.21
|
SECONDARY outcome
Timeframe: Assessed at 8 weeksPopulation: Note that only 30 LGBT survivors from the Dyadic Exercise Intervention and only 27 from the Individual Exercise intervention had analyzable blood, which is why the total number of participants differs from other outcome measures.
The secondary aim is to determine the preliminary effect of EXCAP-PA versus survivor-only EXCAP©® on biological endpoints associated with distress: markers of early inflammation serum amyloid A (SAA) among LGBT cancer survivors.
Outcome measures
| Measure |
Dyadic Exercise Intervention for LGBT Cancer Survivors
n=30 Participants
Progressive walking and resistance exercise treatment, prescribed to both cancer survivors and their caregivers (daily walking and 3 times/week resistance prescription for 6 weeks). Cancer survivor and caregiver are also asked to discuss ways they can support one another in a) remaining adherent to exercise, and b) dealing with stress, including LGBT-specific minority stress.
Exercise for Cancer Patients: a standardized, daily, 6 week, home-based, progressive exercise program
|
Individual Exercise Intervention for LGBT Cancer Survivors
n=27 Participants
Progressive walking and resistance exercise treatment, prescribed solely to cancer survivors (daily walking and 3 times/week resistance prescription for 6 weeks). The caregiver is told not to change his/her exercise behavior in any way.
Exercise for Cancer Patients: a standardized, daily, 6 week, home-based, progressive exercise program
|
|---|---|---|
|
Biological Endpoints: Serum Amyloid A
|
666.27 ng/ml
Standard Deviation 219.98
|
968.26 ng/ml
Standard Deviation 1592.59
|
SECONDARY outcome
Timeframe: Assessed at 8 weeksPopulation: Note that only 30 LGBT survivors from the Dyadic Exercise Intervention and only 27 from the Individual Exercise intervention had analyzable blood, which is why the total number of participants differs from other outcome measures.
The secondary aim is to determine the preliminary effect of EXCAP-PA versus survivor-only EXCAP©® on biological endpoints associated with distress: markers of C-reactive protein (CRP) among LGBT cancer survivors.
Outcome measures
| Measure |
Dyadic Exercise Intervention for LGBT Cancer Survivors
n=30 Participants
Progressive walking and resistance exercise treatment, prescribed to both cancer survivors and their caregivers (daily walking and 3 times/week resistance prescription for 6 weeks). Cancer survivor and caregiver are also asked to discuss ways they can support one another in a) remaining adherent to exercise, and b) dealing with stress, including LGBT-specific minority stress.
Exercise for Cancer Patients: a standardized, daily, 6 week, home-based, progressive exercise program
|
Individual Exercise Intervention for LGBT Cancer Survivors
n=27 Participants
Progressive walking and resistance exercise treatment, prescribed solely to cancer survivors (daily walking and 3 times/week resistance prescription for 6 weeks). The caregiver is told not to change his/her exercise behavior in any way.
Exercise for Cancer Patients: a standardized, daily, 6 week, home-based, progressive exercise program
|
|---|---|---|
|
Biological Endpoints: C-reactive Protein
|
860440.91 pg/ml
Standard Deviation 2270252.50
|
133590.00 pg/ml
Standard Deviation 198748.60
|
SECONDARY outcome
Timeframe: Assessed at 8 weeksSocial support from the care partner was measured with the Dyadic Support Questionnaire (DSQ) among LGBT cancer survivors. The DSQ is an 18-item survey based on four functions of social support (emotional, appraisal, instrumental, and informational support). Nine items measure received social support, that is, support provided by the partner. Items are anchored using a Likert scale ranging from 1 to 5 (from not at all to a great deal). Items were summed to create a scale for received support ranging from 9-45, with higher scores indicating more support.
Outcome measures
| Measure |
Dyadic Exercise Intervention for LGBT Cancer Survivors
n=32 Participants
Progressive walking and resistance exercise treatment, prescribed to both cancer survivors and their caregivers (daily walking and 3 times/week resistance prescription for 6 weeks). Cancer survivor and caregiver are also asked to discuss ways they can support one another in a) remaining adherent to exercise, and b) dealing with stress, including LGBT-specific minority stress.
Exercise for Cancer Patients: a standardized, daily, 6 week, home-based, progressive exercise program
|
Individual Exercise Intervention for LGBT Cancer Survivors
n=31 Participants
Progressive walking and resistance exercise treatment, prescribed solely to cancer survivors (daily walking and 3 times/week resistance prescription for 6 weeks). The caregiver is told not to change his/her exercise behavior in any way.
Exercise for Cancer Patients: a standardized, daily, 6 week, home-based, progressive exercise program
|
|---|---|---|
|
Mechanistic Outcomes: Support
|
39.46 score on a scale
Standard Deviation 7.95
|
39.04 score on a scale
Standard Deviation 4.08
|
SECONDARY outcome
Timeframe: Assessed at 8 weeksWe also aim to determine the preliminary effect of EXCAP-PA versus survivor-only EXCAP©® on social support from the care partners intervention adherence (actigraphy) among LGBT cancer survivors. The actigraph features a variable epoch length which can be set between 1 to 240 seconds. Software supplied by the manufacturer was used to determine number of minutes of moderate or higher activity during each assessment period.
Outcome measures
| Measure |
Dyadic Exercise Intervention for LGBT Cancer Survivors
n=32 Participants
Progressive walking and resistance exercise treatment, prescribed to both cancer survivors and their caregivers (daily walking and 3 times/week resistance prescription for 6 weeks). Cancer survivor and caregiver are also asked to discuss ways they can support one another in a) remaining adherent to exercise, and b) dealing with stress, including LGBT-specific minority stress.
Exercise for Cancer Patients: a standardized, daily, 6 week, home-based, progressive exercise program
|
Individual Exercise Intervention for LGBT Cancer Survivors
n=31 Participants
Progressive walking and resistance exercise treatment, prescribed solely to cancer survivors (daily walking and 3 times/week resistance prescription for 6 weeks). The caregiver is told not to change his/her exercise behavior in any way.
Exercise for Cancer Patients: a standardized, daily, 6 week, home-based, progressive exercise program
|
|---|---|---|
|
Mechanistic Outcomes: Adherence
|
12.57 minutes per day
Standard Deviation 7.55
|
15.55 minutes per day
Standard Deviation 9.60
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Assessed at 8 weeksSelf-reported psychological distress among caregivers of LGBT cancer survivors was determined using the Profile of Mood States (POMS) total score. The POMS consists of 30 adjectives that subjects rate on a five-point scale with "1" = "Not at all" and "5" = "Extremely" to describe their moods over the past week. The total score can be calculated by adding the raw scores from tension, depression, anger, fatigue and confusion-focused items and then subtracting the vigour-focused items. This will give a value between -24 and 177, with higher scores indicating higher psychological distress.
Outcome measures
| Measure |
Dyadic Exercise Intervention for LGBT Cancer Survivors
n=32 Participants
Progressive walking and resistance exercise treatment, prescribed to both cancer survivors and their caregivers (daily walking and 3 times/week resistance prescription for 6 weeks). Cancer survivor and caregiver are also asked to discuss ways they can support one another in a) remaining adherent to exercise, and b) dealing with stress, including LGBT-specific minority stress.
Exercise for Cancer Patients: a standardized, daily, 6 week, home-based, progressive exercise program
|
Individual Exercise Intervention for LGBT Cancer Survivors
n=31 Participants
Progressive walking and resistance exercise treatment, prescribed solely to cancer survivors (daily walking and 3 times/week resistance prescription for 6 weeks). The caregiver is told not to change his/her exercise behavior in any way.
Exercise for Cancer Patients: a standardized, daily, 6 week, home-based, progressive exercise program
|
|---|---|---|
|
Self-Reported Distress Among Caregivers
|
2.65 score on a scale
Standard Deviation 16.03
|
6.21 score on a scale
Standard Deviation 17.58
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Assessed at 8 weeksPopulation: Note that only 30 caregivers from the Dyadic Exercise Intervention and only 27 from the Individual Exercise intervention had analyzable blood, which is why the total number of participants differs from other outcome measures.
An exploratory aim is to determine the preliminary effect of EXCAP-PA versus survivor-only EXCAP©® on biological endpoints associated with distress among caregivers of LGBT cancer survivors: serum cortisol.
Outcome measures
| Measure |
Dyadic Exercise Intervention for LGBT Cancer Survivors
n=30 Participants
Progressive walking and resistance exercise treatment, prescribed to both cancer survivors and their caregivers (daily walking and 3 times/week resistance prescription for 6 weeks). Cancer survivor and caregiver are also asked to discuss ways they can support one another in a) remaining adherent to exercise, and b) dealing with stress, including LGBT-specific minority stress.
Exercise for Cancer Patients: a standardized, daily, 6 week, home-based, progressive exercise program
|
Individual Exercise Intervention for LGBT Cancer Survivors
n=27 Participants
Progressive walking and resistance exercise treatment, prescribed solely to cancer survivors (daily walking and 3 times/week resistance prescription for 6 weeks). The caregiver is told not to change his/her exercise behavior in any way.
Exercise for Cancer Patients: a standardized, daily, 6 week, home-based, progressive exercise program
|
|---|---|---|
|
Biological Endpoints of Distress Among Caregivers
|
68.80 ng/ml
Standard Deviation 60.46
|
60.74 ng/ml
Standard Deviation 72.42
|
Adverse Events
Dyadic Exercise Intervention for LGBT Cancer Survivors
Serious events: 1 serious events
Other events: 0 other events
Deaths: 3 deaths
Individual Exercise Intervention for LGBT Cancer Survivors
Serious events: 0 serious events
Other events: 0 other events
Deaths: 2 deaths
Dyadic Exercise Intervention for Caregivers
Serious events: 0 serious events
Other events: 0 other events
Deaths: 1 deaths
Individual Caregivers-No Intervention
Serious events: 0 serious events
Other events: 0 other events
Deaths: 1 deaths
Serious adverse events
| Measure |
Dyadic Exercise Intervention for LGBT Cancer Survivors
n=32 participants at risk
Progressive walking and resistance exercise treatment, prescribed to both cancer survivors and their caregivers (daily walking and 3 times/week resistance prescription for 6 weeks). Cancer survivors and caregivers are also asked to discuss ways they can support one another in a) remaining adherent to exercise, and b) dealing with stress, including LGBT-specific minority stress.
Exercise for Cancer Patients: a standardized, daily, 6 week, home-based, progressive exercise program
|
Individual Exercise Intervention for LGBT Cancer Survivors
n=31 participants at risk
Progressive walking and resistance exercise treatment, prescribed solely to cancer survivors (daily walking and 3 times/week resistance prescription for 6 weeks). The caregiver is told not to change his/her exercise behavior in any way.
Exercise for Cancer Patients: a standardized, daily, 6 week, home-based, progressive exercise program
|
Dyadic Exercise Intervention for Caregivers
n=32 participants at risk
Progressive walking and resistance exercise treatment, prescribed to both cancer survivors and their caregivers (daily walking and 3 times/week resistance prescription for 6 weeks). Cancer survivors and caregivers are also asked to discuss ways they can support one another in a) remaining adherent to exercise, and b) dealing with stress, including LGBT-specific minority stress.
Exercise for Cancer Patients: a standardized, daily, 6 week, home-based, progressive exercise program
|
Individual Caregivers-No Intervention
n=31 participants at risk
A caregiver is defined as any individual whom the cancer survivor nominates as having provided emotional support or tangible assistance without pay during the survivor's cancer experience. No restriction will be placed on caregivers in terms of relationship with the cancer survivor; they can be family members, friends, romantic partners, or community members
|
|---|---|---|---|---|
|
Cardiac disorders
Serious Adverse Event
|
3.1%
1/32 • Number of events 1 • 8 weeks
|
0.00%
0/31 • 8 weeks
|
0.00%
0/32 • 8 weeks
|
0.00%
0/31 • 8 weeks
|
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place